MAKRODENTA - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 64,193 | 52,737 | 63,568 | 84,337 | 83,675 | 84,576 | 71,005 | 42,476 |
| Profit before tax | 8,287 | 18,439 | 11,301 | 13,792 | 11,905 | - | - | - |
| Net profit | 7,873 | 17,517 | 10,736 | 13,102 | 11,310 | 12,601 | 10,228 | 3,875 |
| Equity | 211,512 | 229,029 | 229,765 | 232,867 | 228,582 | 231,183 | 231,411 | 7,065 |
| Liabilities | 714 | 1,500 | 11,463 | 12,022 | 16,391 | 11,675 | 11,605 | 229,368 |
| Non-current assets | 117,505 | 117,505 | 216,825 | 212,695 | 202,695 | 193,912 | 191,716 | 189,620 |
| Current assets | 94,721 | 113,024 | 33,204 | 12,551 | 42,278 | 48,946 | 51,300 | 46,813 |
| Total assets | 212,226 | 230,529 | 250,029 | 225,246 | 244,973 | 242,858 | 243,016 | 236,433 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 7,235 | 7,839 | 7,336 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -40.3% | -17.8% | +20.5% | +32.7% | -0.8% | +1.1% | -16.0% | -40.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 3.7% | 7.6% | 4.3% | 5.8% | 4.6% | 5.2% | 4.2% | 1.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 3.7% | 7.6% | 4.7% | 5.6% | 4.9% | 5.5% | 4.4% | 54.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 12.3% | 33.2% | 16.9% | 15.5% | 13.5% | 14.9% | 14.4% | 9.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 12.9% | 35.0% | 17.8% | 16.4% | 14.2% | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 32.5 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 32,097 | 26,369 | 31,784 | 42,169 | 41,838 | 42,288 | 35,503 | 21,238 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
MAKRODENTA - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-05-04 | 2025-05-14 | 0.15 |
| 2025-05-01 | 2025-05-01 | 0.15 |
| 2025-04-24 | 2025-04-29 | 0.15 |
MAKRODENTA - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company MAKRODENTA is: 0 €
| From | To | Overdue, € |
|---|---|---|
| 2026-08-07 | 2026-09-02 | 0.12 |
| 2026-08-02 | 2026-08-06 | 72.38 |
| 2026-07-16 | 2026-08-01 | 70.14 |
| 2025-02-18 | 2025-02-18 | 91.06 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
MAKRODENTA, UAB (code 141758010) is a Private Limited Liability Company engaged in dental practice care activities. In the latest financial year, 2025, revenue decreased to €42.5K from €71.0K in 2024 and €84.6K in 2023, showing a clear downward three-year trajectory. Net profit also declined, from €12.6K in 2023 and €10.2K in 2024 to €3.9K in 2025. The profit margin narrowed from 14.9% in 2023 and 14.4% in 2024 to 9.1% in 2025, indicating weaker operating performance. Total assets remained broadly stable at €236.4K in 2025, compared with €243.0K in 2024 and €242.9K in 2023. However, the balance sheet structure changed sharply in 2025, with equity falling to €7.1K and liabilities rising to €229.4K. Long-term assets were €189.6K and short-term assets €46.8K. Revenue per employee was €21.2K and profit per employee €1.9K. The very small equity base in 2025 makes return and leverage indicators especially sensitive.